Form 4: Teladoc Health Executive's Routine Stock Transactions
Insider Transaction Report
Teladoc Health's President of U.S. Group Health, Kelly Bliss, reported the vesting and subsequent sale of shares to cover tax obligations from performance and restricted stock units.
Summary
- Kelly Bliss, President, U.S. Group Health at Teladoc Health, Inc. (TDOC), reported transactions involving company common stock.
- On December 1, 2025, Bliss acquired 1,189 shares of common stock from the conversion of performance stock units.
- Also on December 1, 2025, Bliss acquired 3,488 shares and 4,858 shares of common stock from the conversion of restricted stock units.
- Following these acquisitions, Bliss's direct beneficial ownership increased to 56,290, then 59,778, and finally 64,636 shares.
- On December 2, 2025, Bliss disposed of 4,582 shares of common stock at a price of $7.488 per share.
- This disposition was specifically to cover tax withholding obligations related to the vesting of the performance stock unit and restricted stock unit awards.
- After the sale, Bliss's direct beneficial ownership of common stock was 60,054 shares.
Sentiment
Score: 5
Explanation: The filing reports routine executive compensation events (vesting of stock units) and a subsequent sale of shares solely to cover tax withholding obligations, which is a standard practice and does not indicate a change in sentiment or strategic direction.
Future Outlook
This filing does not contain any forward-looking statements or guidance.
Industry Context
This Form 4 reports an executive's personal stock transactions, which are specific to the individual and the company's compensation structure, rather than reflecting broader industry trends or competitive dynamics.
Stakeholder Impact
- Shareholders: Minor dilution from vested shares, but the sale is for tax, not a discretionary move. Overall neutral impact.
Next Steps
- Remaining performance stock units will vest in eight substantially equal quarterly installments after March 1, 2024.
- Remaining restricted stock units (from March 3, 2023 grant) will vest in eight substantially equal quarterly installments after March 1, 2024.
- Remaining restricted stock units (from March 19, 2024 grant) will vest in eight substantially equal quarterly installments beginning on June 1, 2025.
Key Dates
| Date | Description |
|---|---|
| 03/03/2023 | Grant of 41,853 restricted stock units to Kelly Bliss. |
| 03/01/2024 | Kelly Bliss earned 14,263 performance stock units, with one-third vesting and the remainder in eight substantially equal quarterly installments. One-third of 41,853 restricted stock units granted on March 3, 2023, also vested. |
| 03/19/2024 | Grant of 58,300 restricted stock units to Kelly Bliss. |
| 06/01/2025 | Beginning of eight substantially equal quarterly installments for the remainder of 58,300 restricted stock units granted on March 19, 2024. |
| 12/01/2025 | Conversion of 1,189 performance stock units to common stock. Conversion of 3,488 restricted stock units to common stock. Conversion of 4,858 restricted stock units to common stock. |
| 12/02/2025 | Sale of 4,582 shares of common stock at $7.488 per share to cover tax withholding. |
| 12/03/2025 | Filing date of the Form 4. |
Recommendation
holdThis Form 4 details routine executive compensation events, specifically the vesting of performance and restricted stock units and a subsequent sale of shares to cover tax obligations. Such transactions are standard practice and do not typically signal a change in the company's fundamentals or the executive's confidence in the company. Therefore, it provides no new information to alter an existing investment thesis, warranting a 'hold' recommendation based solely on this filing.
Keywords
Teladoc Health, TDOC, Form 4, insider transaction, executive compensation, stock units, Kelly Bliss, stock sale, vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.